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ALERT 
Osmophobia, the fear of odors, is a potential risk factor for suicidality in patients 
with migraine headaches.14 
 
Fear of needles and injections can interfere with a patient’s preventive care and 
treatment.12 
 
OVERVIEW 
Specific phobia is a category of anxiety disorder defined in the DSM-5: Diagnostic and 
statistical manual of mental disorders as the experience of fear or anxiety related to a 
specific object or situation that does not correlate to the level of danger presented by the 
object or situation. The exaggerated fear can lead to significant distress and impaired social 
or occupational functioning. The basis of the disorder is the relationship of the unreasonable 
fear or anxiety to a distinct object or entity called the phobic stimulus.1 The American 
Psychiatric Association (APA) further defines specifiers related to common phobic stimuli, 
including animals (e.g., spiders, insects, dogs), the natural environment (e.g., heights, 
storms, water), blood injection injury (e.g., needles, invasive medical procedures), 
situational (e.g., airplanes, elevators, enclosed spaces), and other (e.g., situations that may 
lead to choking or vomiting, or for children, loud noises or costumed characters).1  
 
Specific phobias can be rooted to fears that are either innate or learned secondary to 
exposure. In either situation, the fear response is excessive and leads to strenuous efforts 
to avoid the object or situation that provokes the fear.7 Along with avoidance, other 
characteristic responses include hyperarousal and distorted thinking related to the feared 
object or situation.4 The physical hyperarousal can be severe and involve symptoms 
consistent with panic (e.g., palpitations, shortness of breath, nausea, fear of dying).1 
Patients may be aware that the fear they experience is not consistent with the danger; 
however, that insight does not mitigate the response.6 
 
Specific phobias typically have an early age of onset, beginning in childhood and, in most 
cases, persisting through adulthood. Fears in childhood are common. If a child experiences 
a transient fear that does not cause significant impairment, this would not be considered a 
specific phobia.1 Females experience specific phobias more often than males, and the 
experience of a specific phobia is typically associated with the experience of other 
psychiatric disorders.15 There is also evidence that patients who experience two subtypes of 
specific phobias have a significantly higher likelihood of developing generalized anxiety 
disorder, obsessive-compulsive disorder (OCD), or both than patients who experience only 
one specific phobia.9 In addition, there is evidence that specific phobias are associated with 
certain medical conditions, including cardiac disease, migraine, respiratory conditions, and 
gastrointestinal disorders.16 
 
The most frequently experienced specific phobia is fear of animals, with snakes 
(ophidiophobia or ophiophobia) and spiders (arachnophobia), being among the most 
common.17 Other fears that are common specific phobias include fear of heights 
(acrophobia), fear of flying (aerophobia), and fear of closed spaces (claustrophobia).6 Fear 
of injections or needles (trypanophobia) is another fear commonly experienced by children, 
adolescents, and adults. This fear can have a negative impact on general health by 
inhibiting participation in preventive care measures (e.g., receiving flu vaccines, follow-up 
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treatments).12 Lack of treatment of phobias, in general, can have a negative impact on 
mental health.6  
 
Assessing for specific phobias can be done via standardized assessment tools such as the 
Circumscribed Fear Measure,11 the Diagnostic Interview Schedule,6 or via tools addressing 
the specific phobic stimuli (e.g., Snake Questionnaire [SNAQ], Spider Questionnaire 
[SPQ]).17 Unstructured interviews can also be used to assess the presence of a specific 
phobia. The evaluation can be made based on the patient’s description of the fear, the fact 
that the fear is out of proportion to the danger it presents, that it is persistent, typically 
lasting for 6 months or more, and that it is not more appropriately attributed to another 
condition.1 
 
EDUCATION 
• Establish a rapport with the patient, family, and designated support person that 
encourages questions. Answer them as they arise.  
• Consider the patient’s, family’s, and designated support person’s values and goals in the 
decision-making process.  
• Assist the patient, family, and designated support person with recognizing signs and 
symptoms of acute exacerbation of the illness.  
• Explain the manifestations of the illness and expected progression of symptoms if the 
patient experiences a relapse. Describe what the family and designated support person 
are likely to see, hear, and experience (e.g., exaggerated fear of an object or situation 
to the extent that even the thought of an encounter with the object or situation can 
cause significant distress). Advise the patient, family, and designated support person of 
steps to take if relapse occurs.  
• Explain to the patient, family, and designated support person that the main goal is to 
provide a safe, secure place to receive treatment.  
• Explain how the behavioral health unit may be different than other settings. Interaction 
is promoted between patients and staff, and group meetings are encouraged. To ensure 
patients’ safety, they are checked on frequently throughout the day.  
• Educate the family and designated support person regarding the nature of psychiatric 
illness and expected signs and symptoms (e.g., exaggerated fear of an object or 
situation, leading to painstaking efforts at avoidance or the experience of debilitating 
symptoms of anxiety, including panic, or both).  
• Assist the patient, family, and designated support person with engaging and 
participating as drivers of the plan of care.  
• Explain the importance of following the medication regimen as ordered. The patient 
should not alter the dose or stop taking the medication even if symptoms have subsided 
and he or she is feeling better.  
 
ASSESSMENT  
1. Perform hand hygiene.  
2. Introduce yourself to the patient, family, and designated support person.  
3. Verify the correct patient using two identifiers.  
4. Assess the patient’s mental status and ability to understand information and 
participate in decisions. Include the patient as much as possible in all decisions.  
5. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. Use an 
organization-approved standardized tool for suicide assessment.8 
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6. Evaluate the patient’s, family’s, and designated support person’s understanding of 
the patient’s illness.  
7. Assess and discuss the patient’s goal for treatment.  
8. Collaborate with the patient, family, and designated support person to develop a plan 
of care.  
9. Identify the patient’s psychiatric advance directives, if available.  
10. Determine the patient’s desire for the family or designated support person to be kept 
informed and involved in treatment.  
11. Determine the family’s or designated support person’s ability to support the patient 
during treatment.  
12. Assess the patient for the presence of specific phobias, realizing that patients with 
more than one specific phobia may be at higher risk for depression and OCD.9 
13. Assess the patient’s level of dysfunction related to the specific phobia, including level 
of avoidance, as well as emotional and physical discomfort experienced. 
14. Assess the patient for comorbid psychiatric disorders.15 
15. Assess the impact of the specific phobia on the patient’s general health and well-
being, including assessment of medical conditions that may be related to the specific 
phobia.16 
16. Assess for a history of and current health problems that may be the result of the 
specific phobia; for example, influenza from avoiding injections, or advanced cancer 
from avoiding screening and appropriate medical tests and procedures. 
 
STRATEGIES  
1. Perform hand hygiene.  
2. Verify the correct patient using two identifiers.  
3. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. Use an 
organization-approved standardized tool for suicide assessment.8 If homicidal or 
suicidal ideation is present, implement appropriate precautions based on the 
patient's status. 
4. Explain the strategies to the patient, family, and designated support person and 
ensure that they agree to treatment. 
5. Maintain a calm, collaborative communication approach, avoiding the use of 
coercion. 
6. Create an environment of trust that allows the development of a therapeutic 
relationship.  
7. Orient the patient to the unit. Include discussion of unit routines, guidelines, 
patient’s rights and expectations, and schedules. Inform the patient that he or she 
will be checked on frequently throughout the stay.  
8. Create an environment that advocates for the patient’s needs using an 
interdisciplinary team. Engage the team in collaborative assessment and treatment 
planning with the patient.  
9. Engage the patient in treatment, including participation in therapeutic groups and 
individual sessions.  
10. Administer psychiatric medications as ordered and monitor the patient’s response to 
the medications.  
11. Monitor the patient’s responses and social interactions in the milieu; reinforce 
appropriate social skills.  
12. Implement appropriate precautions based on the patient’s status.  
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13. Respond to crisis in a calm, therapeutic, and nonthreatening manner. Use the least 
restrictive interventions to prevent harm to patients or staff.  
14. Explore the patient’s concerns and fears to elicit information regarding potential 
phobias and their impact on the patient’s daily life. 
 
Rationale: Patients typically do not seek treatment for specific phobias and 
tend to address their fears through avoidance. The avoidance may involve 
extreme measures that can impact a person’s activities of daily living.6 
 
15. Assess the patient’s insight into his or her fears and anxieties and assist him or her 
with understanding the nature of the disorder and available treatment options. 
Remain nonjudgmental and empathic, reducing the patient’s discomfort and shame. 
Offer hope that the patient’s phobias can be alleviated through treatment. 
 
Rationale: At times patients experience shame related to their phobias, and 
they are uncomfortable discussing them.5  
 
17. Collaborate with the patient, family, designated support person, and team in 
planning for patient discharge and follow-up care.  
18. Provide the appropriate education related to medications, crisis management, and 
follow-up care to the patient, family, and designated support person at the time of 
discharge.  
19. Explain to the patient, family, and designated support person that ongoing treatment 
is vital to continuing recovery. Making and keeping follow-up appointments is critical.  
20. Perform hand hygiene.  
21. Document the strategies in the patient’s record. 
 
REASSESSMENT 
1. Reassess the patient’s pain status and provide appropriate pain management (e.g., 
medication, relaxation, mindfulness skills). 
2. Reassess the impact of specific phobia on the patient’s daily function. 
 
EXPECTED OUTCOMES 
• The patient’s ability to function is not impaired by fears in response to specific phobias. 
• The patient can manage responses to specific phobias effectively and participate in the 
assessment process. 
 
UNEXPECTED OUTCOMES 
• The patient experiences increased fear related to specific phobias. 
• The patient’s ability to function is negatively impacted by specific phobias, and he or she 
has difficulty participating in the assessment process. 
 
DOCUMENTATION 
• Education  
• Patient’s behaviors and response to interventions  
• Patient’s progress toward goals  
• Assessment of pain, treatment if necessary, and reassessment 
• Patient’s ability to replace avoidance and effectively manage response to specific phobias  
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ADOLESCENT CONSIDERATIONS 
• Approximately one half of adolescents diagnosed with autism spectrum disorder also 
experience an anxiety disorder, with the majority experiencing specific phobias.2 In most 
cases, the phobias experienced are unusual, such as a fear of toilets or machines.10 The 
phobias can significantly impact learning and daily functioning.10 
 
OLDER ADULT CONSIDERATIONS 
• Phobias related to blood and injection injury can have a significant impact on an older 
adult’s health.13 
 
SPECIAL CONSIDERATIONS 
• Pathological fear of childbirth (tokophobia) is a condition that can affect any pregnant 
patient but is more likely to be experienced by a patient in her first pregnancy.3 It is also 
more likely in women who have existing psychiatric disorders, particularly depressive 
disorders.3 It is of concern because it can lead to interruption of the pregnancy, 
sterilization, or a request for a cesarean delivery.3 
 
 
REFERENCES 
1. American Psychiatric Association (APA). (2013). Anxiety disorders. In DSM-5: Diagnostic 
and statistical manual of mental disorders (5th ed., pp. 189-233). Washington, DC: Author. 
(classic reference)* (Level VII) 
2. Burton, P., Palicka, A., Williams, T.I. (2017). Treating specific phobias in young people 
with autism and severe learning difficulties. The Cognitive Behaviour Therapist, 10, e21. 
doi:10.1017/S1754470X17000241 (Level VI) 
3. Calderani, E. and others. (2019). Tocophobia in the DSM-5 era: Outcomes of a new cut-
off analysis of the Wijma delivery expectancy/experience questionnaire based on clinical 
presentation. Journal of Psychosomatic Research, 116, 37-43. 
doi:10.1016/j.jpsychores.2018.11.012 (Level VI) 
4. Capriola, N.N., Booker, J.A., Ollendick, T.H. (2017). Profiles of temperament among 
youth with specific phobias: Implications for CBT outcomes. Journal of Abnormal Child 
Psychology, 45(7), 1449–1459. doi:10.1007/s10802-016-0255-4 (Level VI) 
5. de Oliveira-Souza, R. (2018). Phobia of the supernatural: A distinct but poorly recognized 
specific phobia with an adverse impact on daily living. Frontiers in Psychiatry, 9, 590. 
doi:10.3389/fpsyt.2018.00590 
6. Eaton, W.W., Bienvenu, O.J., Miloyan, B. (2018). Specific phobias. The Lancet Psychiatry, 
5(8), 678-686. doi:10.1016/S2215-0366(18)30169-X 
7. Garcia, R. (2017). Neurobiology of fear and specific phobias. Learning & Memory, 24(9), 
462-471. doi:10.1101/lm.044115.116 
8. Joint Commission, The. (2020). National patient safety goals. Behavioral health care 
accreditation program. Retrieved February 28, 2020, from 
https://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-
safety-goals/npsg_chapter_bhc_jan2020.pdf (Level VII)  
9. Lieb, R. and others. (2016). Impact of specific phobia on the risk of onset of mental 
disorders: A 10-year prospective-longitudinal community study of adolescents and young 
adults. Depression and Anxiety, 33(7), 667-675. doi:10.1002/da.22487 (Level VI) 
10. Maskey, M. and others. (2019). A randomised controlled feasibility trial of immersive 
virtual reality treatment with cognitive behaviour therapy for specific phobias in young 
  
 
Anxiety: Specific Phobias Assessment 
(Behavioral Health) - CE 
 
Copyright © 2020, Elsevier, Inc. All rights reserved.               6 of 6 
people with autism spectrum disorder. Journal of Autism and Developmental Disorders, 
49(5), 1912–1927. doi:10.1007/s10803-018-3861-x (Level II) 
11. McCraw, K.S., Valentiner, D.P. (2015). The Circumscribed Fear Measure: Development 
and initial validation of a trans-stimulus phobia measure. Psychological Assessment, 27(2), 
403–414. doi:10.1037/pas0000046 (Level VI) 
12. McLenon, J., Rogers, M.A.M. (2019). The fear of needles: A systematic review and meta-
analysis. Journal of Advanced Nursing, 75(1), 30-42. doi:10.1111/jan.13818 (Level I) 
13. Miloyan, B., Eaton, W.W. (2016). Blood-injection-injury phobia in older adults. 
International Psychogeriatrics, 28(6), 897–902. doi:10.1017/S1041610215002331 (Level 
VI) 
14. Park, S.P., Seo, J.G., Lee, W.K. (2015). Osmophobia and allodynia are critical factors for 
suicidality in patients with migraine. The Journal of Headache and Pain, 16, 529. 
doi:10.1186/s10194-015-0529-1 (Level VI) 
15. Wardenaar, K.J. and others. (2017). The cross-national epidemiology of specific phobia 
in the world mental health surveys. Psychological Medicine, 47(10), 1744–1760. 
doi:10.1017/S0033291717000174 (Level VI) 
16. Witthauer, C. and others. (2016). Associations of specific phobia and its subtypes with 
physical diseases: An adult community study. BMC Psychiatry, 16, 155. 
doi:10.1186/s12888-016-0863-0 (Level VI) 
17. Zsido, A.N. and others. (2018). Short versions of two specific phobia measures: The 
snake and the spider questionnaires. Journal of Anxiety Disorders, 54, 11-16. 
doi:10.1016/j.janxdis.2017.12.002 (Level VI) 
 
 
*In these skills, a “classic” reference is a widely cited, standard work of established 
excellence that significantly affects current practice and may also represent the foundational 
research for practice. 
 
 
Elsevier Skills Levels of Evidence 
• Level I - Systematic review of all relevant randomized controlled trials 
• Level II - At least one well-designed randomized controlled trial 
• Level III - Well-designed controlled trials without randomization 
• Level IV - Well-designed case-controlled or cohort studies 
• Level V - Descriptive or qualitative studies 
• Level VI - Single descriptive or qualitative study 
• Level VII - Authority opinion or expert committee reports 
 
 
Author: Loraine Fleming, DNP, APRN, PMHNP-BC, PMHCNS-BC 
 
Published: Elsevier COVID-19 HealthCare Hub (https://covid-19.elsevier.health/#toolkits), 
April 2020 
